Loading...
Market
What will be the first major application of Cradle's cryo technology?
5
Resolution / Starting Odds
Organ transplants • 33%
Long-distance space travel • 33%
Medical research • 33%
Official announcement from Cradle or healthcare news sources
Story
Laura Deming's Cradle Raises $48M for Reversible Cryo Technology
Jun 3, 2024, 01:59 PM
Cradle, a company co-founded by Laura Deming and Hunter Cole Davis, is pioneering a new approach to cryo preservation and the revival of bodies and brains. They have successfully raised $48 million and assembled a world-class team of scientists and engineers. The technology aims to create reversible cryo solutions, similar to hibernation pods seen in space movies, which could be valuable for organ transplants in the short term and enable new possibilities in the long term. The team behind Cradle is noted for matching the ambition of their innovative idea.
View original story
Similar markets
Long-term space travel • 33%
Organ transplants • 33%
Medical research • 33%
Brain tissue • 25%
Heart tissue • 25%
Liver tissue • 25%
Lung tissue • 25%
Human trial initiation • 25%
Partnership with major institution • 25%
New funding round • 25%
Successful cryopreservation of larger mammal • 25%
Yes • 50%
No • 50%
Less than $50M • 25%
$50M - $100M • 25%
$100M - $200M • 25%
More than $200M • 25%
Sequoia Capital • 25%
Andreessen Horowitz • 25%
Greylock Partners • 25%
SoftBank Vision Fund • 25%
Propulsion System • 33%
Landing Mechanism • 33%
Payload Capacity • 33%